PubMed

Human breast cancer cell-mediated bone collagen degradation requires plasminogen activation and matrix metalloproteinase activity.

Morgan H, Hill PA.

Cancer Cell Int. 2005 Feb 8;5(1):1.PMID: 15701164 [PubMed - as supplied by publisher]Related articlesFree article

Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity.

Netzel-Arnett S, Mitola DJ, Yamada SS, Chrysovergis K, Holmbeck K, Birkedal-Hansen H, Bugge TH.

J Biol Chem. 2002 Nov 22;277(47):45154-61. Epub 2002 Aug 20.PMID: 12192005 [PubMed - indexed for MEDLINE]Related articlesFree article

Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.

de Bart AC, Quax PH, Löwik CW, Verheijen JH.

J Bone Miner Res. 1995 Sep;10(9):1374-84.PMID: 7502710 [PubMed - indexed for MEDLINE]Related articles

Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.

Davis GE, Pintar Allen KA, Salazar R, Maxwell SA.

J Cell Sci. 2001 Mar;114(Pt 5):917-30.PMID: 11181175 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.

Azzam HS, Arand G, Lippman ME, Thompson EW.

J Natl Cancer Inst. 1993 Nov 3;85(21):1758-64.PMID: 8411260 [PubMed - indexed for MEDLINE]Related articles

Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.

Rosenthal EL, Johnson TM, Allen ED, Apel IJ, Punturieri A, Weiss SJ.

Cancer Res. 1998 Nov 15;58(22):5221-30.PMID: 9823336 [PubMed - indexed for MEDLINE]Related articlesFree article

Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity.

Farina AR, Coppa A, Tiberio A, Tacconelli A, Turco A, Colletta G, Gulino A, Mackay AR.

Int J Cancer. 1998 Mar 2;75(5):721-30.PMID: 9495240 [PubMed - indexed for MEDLINE]Related articles

ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.

Baricos WH, Cortez SL, el-Dahr SS, Schnaper HW.

Kidney Int. 1995 Apr;47(4):1039-47.PMID: 7540230 [PubMed - indexed for MEDLINE]Related articles

Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.

Ronday HK, Smits HH, Quax PH, van der Pluijm G, Löwik CW, Breedveld FC, Verheijen JH.

Br J Rheumatol. 1997 Jan;36(1):9-15.PMID: 9117184 [PubMed - indexed for MEDLINE]Related articlesFree article

Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation system.

Smit JW, van der Pluijm G, Romijn HA, Löwik CW, Morreau H, Goslings BM.

Thyroid. 1999 Sep;9(9):913-9.PMID: 10524570 [PubMed - indexed for MEDLINE]Related articles

Plasminogen activator mediated degradation of subendothelial extracellular matrix by human squamous carcinoma cell lines.

Niedbala MJ, Sartorelli AC.

Cancer Commun. 1990;2(5):189-99.PMID: 2142433 [PubMed - indexed for MEDLINE]Related articles

Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines.

Stonelake PS, Jones CE, Neoptolemos JP, Baker PR.

Br J Cancer. 1997;75(7):951-9.PMID: 9083329 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen.

Farina AR, Tacconelli A, Cappabianca L, Gulino A, Mackay AR.

Eur J Biochem. 2002 Sep;269(18):4476-83.PMID: 12230559 [PubMed - indexed for MEDLINE]Related articlesFree article

Human breast-cancer cells stimulate the fusion, migration and resorptive activity of osteoclasts in bone explants.

Tumber A, Morgan HM, Meikle MC, Hill PA.

Int J Cancer. 2001 Mar 1;91(5):665-72.PMID: 11267975 [PubMed - indexed for MEDLINE]Related articles

Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer.

Kim TD, Song KS, Li G, Choi H, Park HD, Lim K, Hwang BD, Yoon WH.

BMC Cancer. 2006 Aug 18;6:211.PMID: 16916471 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of serine proteinase inhibitors on bone resorption in vitro.

Tumber A, Papaioannou S, Breckon J, Meikle MC, Reynolds JJ, Hill PA.

J Endocrinol. 2003 Sep;178(3):437-47.PMID: 12967336 [PubMed - indexed for MEDLINE]Related articlesFree article

Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma.

Moser TL, Young TN, Rodriguez GC, Pizzo SV, Bast RC Jr, Stack MS.

Int J Cancer. 1994 Feb 15;56(4):552-9.PMID: 8112891 [PubMed - indexed for MEDLINE]Related articles

Proteolysis in human breast cancer.

Garbett EA, Reed MW, Stephenson TJ, Brown NJ.

Mol Pathol. 2000 Apr;53(2):99-106.PMID: 10889910 [PubMed - indexed for MEDLINE]Related articlesFree article

Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways.

Montgomery AM, De Clerck YA, Langley KE, Reisfeld RA, Mueller BM.

Cancer Res. 1993 Feb 1;53(3):693-700.PMID: 8425205 [PubMed - indexed for MEDLINE]Related articlesFree article

In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.

Haupt LM, Thompson EW, Trezise AE, Irving RE, Irving MG, Griffiths LR.

BMC Cancer. 2006 Jan 24;6:18.PMID: 16430785 [PubMed - indexed for MEDLINE]Related articlesFree article